NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) — Evercel, Inc. (OTC: EVRC) today announced the conversion of its convertible note in SharpSpring (NASDAQ: SHSP). SHSP Holdings, the entity that holds the note, will receive 1,241,634 shares of SharpSpring common stock, which reflects an agreement Evercel reached with SharpSpring to accelerate part of the interest not yet earned on the note but forgo interest that would have been earned had the note been held through maturity or been forced converted by the Company. Further information regarding the terms of the conversion can be found in SharpSpring’s Form 8-K, filed with the SEC earlier today.
About Evercel: New York City-based Evercel is a publicly traded holding company that oversees and manages subsidiary companies. Due to Evercel’s limited number of shareholders and its decision at present not to register with the SEC, Evercel is not obligated to publicly report business or financial information. From time-to-time, Evercel chooses to voluntarily report information. Evercel may change its reporting practices at any time, in its discretion and without notice.
Please Note: Statements in this announcement that are not historical facts are “forward-looking statements”, which may involve material risks and uncertainties. Evercel cautions readers not to place undue reliance on forward-looking statements. The information in this announcement does not purport to be a complete disclosure of the matters addressed, and you should not rely on it as being complete.
CONTACT: For further information, please contact: [email protected]
Latest posts by GlobeNewswire (see all)
- Parcel Pending Predicts Top 2019 Holiday Shopping Season Trends for Retailers - October 15, 2019
- Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia - October 15, 2019
- WindMIL Therapeutics and University of California, Irvine Announce Collaboration to Collect Bone Marrow from Patients with Gliomas to Develop Marrow Infiltrating Lymphocytes (MILs™) - October 15, 2019